...
ELVLARGE

Elevance Health Inc.

HealthcareMedical - Healthcare Plans
$320.00
$0.03(-0.94%)
52W$273.71
$458.75
FinancialsValuationvs HUM
Updated Mar 2, 12:00 AM
RSI38
RS Rating36/99
Beta0.20
Volatility39%
F-Score6/9
Mkt Cap$70.6B
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Elevance Health Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 36), showing significant lag compared to the market leaders. Earnings growth of 36% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.

Relative Strength
36
out of 99
Lagging
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
0.20
vs S&P 500
LOW VOL
52W Position
25%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$350.14
50 SMA > 100 SMA$343.12
100 SMA > 150 SMA$331.62
150 SMA > 200 SMA$339.29

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$336.44-4.89%BELOW
50 SMA$350.14-8.61%BELOW
100 SMA$343.12-6.74%BELOW
150 SMA$331.62-3.50%BELOW
200 SMA$339.29-5.68%BELOW

Price Performance

1D-0.9%
1W-4.7%
1M-6.4%
3M-5.4%
6M+3.1%
YTD-9.7%
1Y-19.4%
3Y-12.0%
52-Week Trading Range25% from low
$320.00
52W Low$273.71
52W High$458.75

Technical Indicators

RSI (14)BEARISH
38.5
305070
VCP ScoreCOOL
5/10
Base depth: 22.5%

Risk Profile

Beta
0.20
52W Vol
39%
ATR
$11.13
Max DD (1Y)
-39%

Volume Analysis

Today
320
50D Avg
1.32M
Vol Ratio
0.00x
Liquidity
LIQUID

Earnings Momentum

Q1'250%
$9.61
Q2'25-22%
$7.72
Q3'25+22%
$5.32
Q4'25+36%
$2.47
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+9.64%
5 Years:+10.27%
3 Years:+8.26%
TTM:+12.37%

Compounded Profit Growth

10 Years:+10.35%
5 Years:+6.92%
3 Years:+1.14%
TTM:-1.91%

Stock Price CAGR

10 Years:+9.37%
5 Years:+0.54%
3 Years:-12.01%
1 Year:-19.37%

Return on Equity

10Y Avg:14.7%
5Y Avg:15.6%
3Y Avg:14.6%
Last Year:12.9%

Key Metrics

Market Cap$70.6B
Gross Margin56.2%
Net Margin2.8%
Piotroski F-Score6/9

More ELV Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

ELV vs HUMHUM

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 36 meansELV outperformed 36% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.20 means 80% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 6/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 5/10 with COOL status.

Frequently Asked Questions

Is ELV in an uptrend right now?

ELV has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is ELV overbought or oversold?

ELV's RSI (14) is 38. The stock is in neutral territory, neither overbought nor oversold.

Is ELV outperforming the market?

ELV has a Relative Strength (RS) Rating of 36 out of 99. ELV is currently lagging the broader market.

Where is ELV in its 52-week range?

ELV is trading at $320.00, which is 70% of its 52-week high ($458.75) and 25% above its 52-week low ($273.71).

How volatile is ELV?

ELV has a Beta of 0.20 and 52-week volatility of 39%. It's less volatile than the S&P 500 - generally more stable.